REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
